SUMMARY
- Ai Health Highway has secured $1 million in its seed funding round led by Turbostart.
- This funding round is part of a bigger $1.5 million investment, which involves participation from prominent backers.
- The funds will be deployed in expanding its operations in India, speeding up approvals from international health authorities and more.
Healthtech Ai Health Highway has secured $1 million in its seed funding round led by Turbostart. This funding round is part of a bigger $1.5 million investment, which involves participation from prominent backers like Rainmatter by Zerodha, The Chennai Angels, BITS BioCyTiH Foundation, and other venture capitalists.
The funds will be deployed in expanding its operations in India, speeding up approvals from international health authorities, and enhancing its artificial intelligence and machine learning technologies in the area of cardiovascular and respiratory health, as mentioned in a news announcement.
Established in 2018 by Satish Jeevannavar, Ai Health Highway develops digital screening devices that help in the early identification of non-communicable diseases (NCDs) and improve access to healthcare through its AI-powered stethoscope, AiSteth. The company’s goal is to decrease the number of premature deaths from NCDs by 30% by the year 2030.
AiSteth supports healthcare professionals and laypeople in understanding heart sounds, aiding in making precise medical decisions. It employs sophisticated AI and signal processing techniques to upgrade standard stethoscopes into effective screening instruments that can identify serious heart conditions early on.
The AI-enhanced stethoscope fits into current medical practices, providing primary care doctors with superior tools for capturing, analyzing, and sharing heart sound data, thereby making healthcare more accessible and cost-effective.
